Published 1 day ago • loading... • Updated 13 hours ago

Dynavax Files Preliminary Proxy Statement

On April 3, 2025, Dynavax filed preliminary proxy materials with the SEC for its upcoming Annual Meeting.
Deep Track began its campaign in August 2024, demanding changes to Dynavax's business strategy.
Dynavax engaged extensively with Deep Track, even offering four settlement proposals that included board changes.
The Board found Deep Track's candidate, Brett Erkman, unqualified due to a lack of relevant skills.
According to Dynavax, Deep Track's short-term plan risks long-term value, while Dynavax focuses on sustained growth.

Insights by Ground AI

Does this summary seem wrong?

27 Articles

All

Left

Center

Right

Los Angeles Downtown News - The Voice of Downtown Los Angeles…

+24 Reposted by 24 other sources

Center

Dynavax Files Preliminary Proxy Statement

Dynavax's Board is Overseeing Record Operational and Financial Performance

1 day ago

Read Full Article

pressreach.com

Dynavax Files Preliminary Proxy Statement - PressReach

Dynavax’s Board is Overseeing Record Operational and Financial Performance Outlines Extensive Engagement with Deep Track and Multiple Attempts to Reach a Resolution EMERYVILLE, Calif., April 3, 2025 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX) (“Dynavax” or the “Company”), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today filed its preliminary proxy materials with the Securit…

13 hours ago

Read Full Article

stocktitan.net

Dynavax Fights $950M Revenue Giant's Board Control: 300% Returns at Stake

Record HEPLISAV-B sales hit $268M with 44% market share as Dynavax defends growth strategy against activist investor seeking board control. See full analysis.

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year